Abstract 225: A Novel SELF-Pathway for Management of Patients Presenting with Unexplained-Syncope Appropriately Identify High Risk Patients as Validated by the OESIL Score

Background: The OESIL risk score for the evaluation of syncope is widely used and is based on the presence of 4 risk factors: abnormal ECG, a previous history of cardiovascular diseases, absence of prodromal symptoms, and age greater than 65 years. We assessed the appropriateness of our novel SELF-SYNCOPE pathway in comparison to this score. Methods: According to the design of our syncope pathway, patients are risk stratified twice using the acronyms of SELF-A (Short period, Early-rapid onset, Loss of consciousness, Full recovery) and SELF-B (Structural heart disease, abnormal Ecg, and arrhythmia Fib/FL). 1462 patients were prospectively followed and were divided into four groups according to having SELF-A and SELF-B criteria. 762 patients met group I (SELF A+/B+) and group IV (SELF A-/B-) and were compared to the OESIL risk score. Results: Group I patients were older and more likely to have hypertension (74% vs. 45%), diabetes (25% vs. 16%), heart failure (9% vs. 3%), and coronary disease (21% vs. 4%); p Conclusions: Using a simple novel pathway for patients presenting with unexplained syncope effectively identifies high risk patients as validated by the OESIL risk score.